National Marrow Donor Program® (NMDP)/Be The Match® Names Christina Melief, Ph.D., Senior Scientific Advisor
July 25, 2023 17:01 ET
|
Be The Match
Dr. Melief will work to simplify and accelerate the acquisition of cord blood units for transplant and cell and gene therapies through expanded access for transplant centers, cord blood banks, and...
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
July 10, 2023 09:40 ET
|
Be The Match
MINNEAPOLIS, July 10, 2023 (GLOBE NEWSWIRE) -- In anticipation of Cord Blood Awareness Month this July, Be The Match BioTherapies®, an organization offering solutions for companies developing and...
CPABC: Terrace housing starts slow, but major project investment continues to boost economic activity in Northwest B.C.
April 03, 2023 18:00 ET
|
Chartered Professional Accountants of British Columbia
SMITHERS, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) -- According to BC Check-Up: Invest, an annual report by the Chartered Professional Accountants of British Columbia (CPABC) on investment...
Yamaha Bicycles Adds Northwest Regional Field Sales and Marketing Rep
February 28, 2023 12:00 ET
|
Yamaha Motor Corp., USA
CYPRESS, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Yamaha Bicycles continues its field sales and marketing team growth, most recently adding Nate Espinosa as the new representative for the northwest...
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test
September 28, 2020 07:00 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S. Food and Drug...
Le New England Journal of Medicine publie les résultats finaux positifs d’une étude de phase I/IIa consacrée au BIVV001 dans le traitement de l’hémophilie A sévèr
September 10, 2020 01:00 ET
|
Sanofi
Le BIVV001 est le premier facteur VIII de remplacement expérimental, indépendant du facteur von Willebrand, ayant le potentiel de transformer le traitement de l’hémophilie A. Sa conception unique...
New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A
September 10, 2020 01:00 ET
|
Sanofi
BIVV001 is the first investigational factor...
Bloodworks Northwest Now Tests All Donors for COVID-19 Antibodies Looking for More Qualified Convalescent Plasma Donors
August 27, 2020 08:30 ET
|
Quotient Limited
Testing Conducted Using the Highly Accurate MosaiQ COVID-19 Antibody Test from Quotient JERSEY, Channel Islands, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Bloodworks Northwest is now offering all blood...
Alaska National Insurance Company, a CopperPoint Insurance Company, named to Ward’s 50® List of Top Performing P&C Insurance Companies for 10th Consecutive Year
August 07, 2020 06:17 ET
|
CopperPoint Insurance Companies
PHOENIX, Aug. 07, 2020 (GLOBE NEWSWIRE) -- CopperPoint Insurance Companies, a western-based super regional commercial insurance company, announced today that Alaska National Insurance Company, part...
Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2
August 04, 2020 09:30 ET
|
Adaptive Biotechnologies
Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19...